Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Yelena Mumblat"'
Supplemental Movie 3. A time lapse movie of proliferating lymphatic endothelial cells (LEC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::100341d0428e0beda5873591132f8fea
https://doi.org/10.1158/0008-5472.22405145
https://doi.org/10.1158/0008-5472.22405145
Supplementary Materials and methods. Contains the description of materials and methods used in the experiments shown in the supplementary figures and additional details for some of the methods and reagents used in the main manuscript which could not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e334abea9baea3b91831956da8266336
https://doi.org/10.1158/0008-5472.22405136
https://doi.org/10.1158/0008-5472.22405136
Supplementary figures 1-7. Contains the 7 supplementary figures (1S to 7S) in PDF format. Fig. 1S: Characterization of the expression of class-3 semaphorin receptors in LEC Fig. 2S: Semaphorins that fail to contract LEC nevertheless induce contractio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38dbcfb2e7a60693de3867f7f6733559
https://doi.org/10.1158/0008-5472.22405133.v1
https://doi.org/10.1158/0008-5472.22405133.v1
Supplemental Movie 2. A time lapse movie showing the effect FR-Sema3C on the proliferation of human umbilical vein derived endothelial cells (HUVEC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f4d1f2bbca6d0656fb0b10a33df4c20
https://doi.org/10.1158/0008-5472.22405148
https://doi.org/10.1158/0008-5472.22405148
Supplemental Movie 1. A time lapse movie of proliferating human umbilical vein derived endothelial cells (HUVEC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4a05c5568b35b63d27e93e729d7125a
https://doi.org/10.1158/0008-5472.22405151
https://doi.org/10.1158/0008-5472.22405151
Supplementary Figure Legends. Contains the figure legends for supplementary figures 1S to 7S.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c332449b73b0158fdc77559863fbf04
https://doi.org/10.1158/0008-5472.22405139
https://doi.org/10.1158/0008-5472.22405139
Autor:
Dror Alishekevitz, Svetlana Gingis-Velitski, Orit Kaidar-Person, Lilach Gutter-Kapon, Sandra D. Scherer, Ziv Raviv, Emmanuelle Merquiol, Yael Ben-Nun, Valeria Miller, Chen Rachman-Tzemah, Michael Timaner, Yelena Mumblat, Neta Ilan, David Loven, Dov Hershkovitz, Ronit Satchi-Fainaro, Galia Blum, Jonathan P. Sleeman, Israel Vlodavsky, Yuval Shaked
Publikováno v:
Cell Reports, Vol 17, Iss 5, Pp 1344-1356 (2016)
Summary: While chemotherapy strongly restricts or reverses tumor growth, the response of host tissue to therapy can counteract its anti-tumor activity by promoting tumor re-growth and/or metastases, thus limiting therapeutic efficacy. Here, we show t
Externí odkaz:
https://doaj.org/article/33aac968c8234da399706c8ab64ff755
Autor:
Noga Sharf Pauker, Omer Adir, Gal Chen, Yelena Mumblat, Maria Poley, Janna Shainsky-Roitman, Lilach Koren, Hanan Abumanhal-Masarweh, Maya Kaduri, Jeny Shklover, Avi Schroeder, Aviram Avital
This chapter explores tumoral barriers for the successful implementation of nanomedicines. Nanotechnologies hold great clinical promise to improve the efficacy of diagnostic and therapeutic anticancer agents. In cancer therapy, many nanotechnologies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf9936c089aedd931a10949ca1a732c7
https://doi.org/10.1201/9781003125259-15
https://doi.org/10.1201/9781003125259-15
Autor:
Yelena Mumblat, Mohammed Alyan, Nadav Noor, Assaf Simon, Omer Adir, Robert Luxenhofer, Jeny Shklover, Nitzan Krinsky, Sivan Ofir, Eran Fridman, Janna Shainsky-Roitman, Ziv Gil, Hadas Gibori, Assaf Zinger, Maria Poley, Tal Dvir, Lilach Koren, Neta Milman, Ronit Satchi-Fainaro, Yoav Binenbaum, Majd Krayem, Lior Liba, Zvi Yaari, Dov Hershkovitz, Avi Schroeder, Michael M. Lübtow, Shira Kasten
Publikováno v:
ACS Nano
Overexpressed extracellular matrix (ECM) in pancreatic ductal adenocarcinoma (PDAC) limits drug penetration into the tumor and is associated with poor prognosis. Here, we demonstrate that a pretreatment based on a proteolytic-enzyme nanoparticle syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6da0ff21dfdbe27c45f6bcd18d040383
https://pubmed.ncbi.nlm.nih.gov/31503443
https://pubmed.ncbi.nlm.nih.gov/31503443
Autor:
Shira Toledano, Ofra Kessler, Keren Ziv, Inbal Nir-Zvi, Gera Neufeld, Yelena Mumblat, Tanya Smolkin
Publikováno v:
Drug Resistance Updates. 29:1-12
The semaphorins were initially characterized as repulsive axon guidance factors. However, they are currently also recognized as important regulators of diverse biological processes which include regulation of immune responses, angiogenesis, organogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8c9654d909bf5738d063c3064ca3cc9
https://doi.org/10.1016/j.drup.2016.08.001
https://doi.org/10.1016/j.drup.2016.08.001